Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology - Van de Werf, F; Bergman, S R; Fox, K A A; DeGeest, H; Hoyng, C F; Sobel, B E; Collen, D (Circulation, 1984)